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Potential and Distribution of Transplanted Hematopoietic Stem Cells in a
Nonablated Mouse Model
By Susan K. Nilsson, Mark S. Dooner, Candi Y. Tiarks, Heinz-Ulrich Weier, and Peter J. Quesenberry
Increasingly, allogeneic and even more often autologous multilineage potential, and maintain a distinct subpopula-
tion with ‘‘stem cell’’ characteristics. The data also suggestsbone marrow transplants are being done to correct a wide
variety of diseases. In addition, autologous marrow trans- a spatial localization of stem cell ‘‘niches’’ to the endosteal
surface, with all donor cells having a high spatial affinityplants potentially provide an opportune means of delivering
genes in transfected, engrafting stem cells. However, de- to this area. However, the level of stem cell engraftment
observed following a transplant of ‘‘stem cells’’ was signifi-spite its widespread clinical use and promising gene therapy
applications, relatively little is known about the mechanisms cantly lower than that expected following a transplant of
the same number of unseparated marrow cells from whichof engraftment in marrow transplant recipients. This is espe-
cially so in the nonablated recipient setting. Our data show the purified cells were derived, suggesting the existence of
a ‘‘nonstem cell facilitator population,’’ which is required inthat purified lineage negative rhodamine 123/Hoechst 33342
dull transplanted hematopoietic stem cells engraft into the a nonablated syngeneic transplant setting.
q 1997 by The American Society of Hematology.marrow of nonablated syngeneic recipients. These cells have
I primitive, rhodamine 123/Hoechst 33342 dull (Rh/Hoedull)stem cells into the marrow of nonablated hosts. These cellsNCREASINGLY, allogeneic and more often autologousbone marrow transplants (BMTs) are being performed
in an effort to correct a wide variety of disorders. In addition, have multilineage potential and undergo maturation and dif-
ferentiation to give equivalent proportions in both the matureautologous marrow transplants potentially provide an oppor-
as well as the primitive stem cell compartment. In additiontune means of delivering genes in transfected stem cells
these cells appear to selectively home to the femoral marrowcapable of engrafting. However, despite widespread clinical
interface.use of BMTs, and promising possibilities in gene therapy
applications, relatively little is known regarding the mecha-
MATERIALS AND METHODSnisms of engraftment in marrow transplant recipients. This
is particularly true in the nonablated recipient setting. Mice. BALB/c H-2D mice were purchased from Charles River
A bone marrow (BM) stem cell is thought to reside in a Laboratories (Wilmington, MA) and housed in a conventional clean
hematopoietic ‘‘niche,’’ or a microenvironment containing facility for at least 1 week before experimental use. All mice received
mouse chow and acidified water ad libitum.specific stromal and extracellular matrix elements. Success-
Cell suspensions. Six to 8-week-old mice were killed by cervicalful long-term BMTs rely on stem cells homing to these
dislocation. BM was collected from femurs, tibiae, and iliac crests.niches. Micklem et al1 were probably the first to attempt to
This was routinely done by thorough grinding in phosphate-buffereddetect chromosomally marked BM cells injected into normal,
saline (PBS) supplemented with 5% heat inactivated (HI) fetal calf
syngeneic recipients. Their studies in mice showed low lev-
serum (FCS; Hyclone, Logan, UT) using a mortar and pestle. The
els (up to 8.5%) of engraftment of T6T6 cells into nonablated bone fragments were washed multiple times, and the supernatant
CBA host marrow, 3 months after a transplant of 20-million cell suspension and wash fractions were filtered through a 40-mm
marrow cells from normal CBA-T6T6 donors. Takada et filter (Becton Dickinson, Franklin Lakes, NJ) to remove large bone
al2,3 also detected only low numbers of T6 marked marrow particles. High lipid concentrations were reduced by the centrifuga-
tion and resuspension of the cells in fresh buffer. The cells werecells after their injection into normal CBA mice. Experi-
ments such as these drove the hypothesis that there are a
limited number of stem cell ‘‘niches,’’ and that these are
virtually all occupied in normal animals with only very low From the Cancer Center, University of Massachusetts Medical
Center, Worcester, MA; and Resource for Molecular Cytogenetics,levels of exchange from injected stem cells.1,4 As a conse-
Life Sciences Division, Lawrence Berkeley National Laboratory,quence, marrow transplants have traditionally been given
Berkeley, CAto ablated hosts, with conventional dogma suggesting that
Submitted November 14, 1996; accepted January 21, 1997.cytoablative therapy with irradiation and/or cytotoxic drugs
P.J.Q. was supported by grants from National Institutes of Diabetesis required to free ‘‘niches’’ from host cells.
and Digestive and Kidney Diseases (NIDDK, Rockville, MD) #49650-More recently, Brecher et al5 and Saxe et al6 successfully 02 and #50222-01. H-U.W. was supported by a grant from the Office
engrafted relatively high numbers of donor murine BM into of Energy Research, Office of Environmental Research, US Department
normal recipients. Brecher et al5 showed engraftment levels of Energy (Washington, DC) under contract DE-AC-03-76SF00098.
from 16% to 25%, 2 to 13 weeks posttransplant of 40 million S.K.N. is a CJ Martin Fellow, granted from the National Health and
Medical Research Council (Canberra, ACT, Australia), and is sup-cells per day for 5 days into normal hosts. Saxe et al6 used
ported by the Our Danny Cancer Fund, University of Massachusetts,chromosomally marked syngeneic marrow cells to show do-
Worcester.nor levels of 0% to 16% in the marrow or spleen, 1 to 6
Address reprint requests to Susan K. Nilsson, PhD, UMMC Can-months posttransplant. Stewart et al7 extended these studies,
cer Center, 373 Plantation St, Suite 202, Worcester, MA 01605.
showing high levels of engraftment (15% to 42%) for over
The publication costs of this article were defrayed in part by page2 years in the marrow of mice injected with 40 million cells
charge payment. This article must therefore be hereby marked
for 5 consecutive days.
‘‘advertisement’’ in accordance with 18 U.S.C. section 1734 solely to
However, these studies have only evaluated unseparated indicate this fact.
marrow, not purified marrow stem cells. In the present study q 1997 by The American Society of Hematology.
0006-4971/97/8911-0032$3.00/0we have shown the successful homing of highly purified,
4013Blood, Vol 89, No 11 (June 1), 1997: pp 4013-4020
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allowed to sit on ice for 5 minutes, so small bone particles would term reconstituting ability were concentrated within the 1st through
3rd percentiles of Hoe fluorescence and then the 1st through 15thsettle out. The cell supernatant, depleted of these fragments, was
then diluted to 107 cells/mL PBS 5% HI FCS. percentiles of Rh fluorescence (Rh/Hoedull).20 Sorted cells were col-
lected on ice, counted, and injected into recipients. ApproximatelyWhen whole BM cell suspensions were to be injected into a
recipient without manipulation, the cells were collected by flushing 12 hours elapsed between removal of donor marrow and injection
into recipients.the femurs and tibiae with cold PBS supplemented with 5% HI FCS.
The cells were filtered as described above, washed, and resuspended Hematopoietic progenitor cell assay. The cloning efficiency of
separated marrow populations was determined by analysis for highfor injection in 0.5 mL of PBS.
Preparation of lineage negative cells. Lineage negative cells proliferative potential colony forming cells (HPP-CFC), using a dou-
ble layer nutrient agar culture system as previously described,21 ex-were isolated in a manner very similar to that previously described
by Bertoncello et al.8 Briefly, low density cells (1.0777 g/cm3) cept for the use of 7 growth factors (interleukin-1 [IL-1], IL-3,
colony-stimulating factor-1 [CSF-1], granulocyte-macrophage col-were isolated by discontinuous density centrifugation using Nyco-
prep for animals (Accurate Chemical and Scientific Corp, Westbury, ony-stimulating factor [GM-CSF], granulocyte colony-stimulating
factor [G-CSF], stem cell factor [SCF], and basic fibroblastic growthNY), washed and resuspended at 108 cells/mL PBS 5% HI FCS.
Cells were labeled with a cocktail of primary antibodies: anti-B220 factor [FGF]) instead of 3 factors. HPP-CFC typically generated
colonies greater than 0.5 mm in diameter consisting of tightly packed(B cells) Coffman9; anti-Mac-1(macrophages) Springer10; anti-Gr-1
(neutrophils) Hestdal11; anti-Lyt-2 (CD8) and anti-L3T4 (CD4) (T cells. Functionally these are defined as primitive cells by their rela-
tive resistance to 5-FU, their synergistic growth factor requirements,cells) Cobbold12 (Becton Dickinson); YW25.12.7 (erythroid precur-
sors) Watt et al13; and TER119 (erythrocytes) a kind gift from Tatsuo and their copurification with long-term reconstituting cells in
vivo.22,23Kina (Chest Disease Research Institute, Kyoto University, Kyoto,
Japan). Each batch of antibody was evaluated by flow cytometric Transplants. Transplant experiments involved a single intrave-
nous infusion of between 2,600 and 10,000 Rh/Hoedull male marrowanalysis, for the concentration which resulted in the greatest shift
in mean channel fluorescence and/or the percentage positive cells cells into nonablated female recipients. After either 6 weeks or 6
months, the presence of donor cells was quantitated using fluores-detected. The optimal dilution for each antibody was in the range
of 1:10 to 1:100 (final). After a 15-minute incubation on ice, the cence in situ hybridization (FISH) and Southern blot analysis. At 6-
weeks postengraftment, the spatial distribution of engrafted cellslabeled cells were washed in PBS 5% HI FCS and resuspended at
108 cells/mL PBS 5% HI FCS. The cells were incubated with sheep was analyzed on sections of whole marrow using FISH.
anti-rat IgG conjugated immunomagnetic polystyrene spheres (M-
Engraftment Quantification450 Dynabeads; Dynal, Lake Success, NY) at 47C for 3 minutes by
adding a 1:1 bead:cell ratio. The beads were suspended in PBS 5% Southern blot analysis. DNA extracts of BM were prepared by
HI FCS, and when added to the cells resulted in 1.5 times the original lysis in 0.15 mol/L NaCl, 0.02 mol/L Tris, 0.02 mol/L EDTA, and
cell volume. Immunomagnetic bead-rosetted cells were removed us- 1% sodium dodecyl sulfate followed by purification using organic
ing a magnetic particle concentrator (Dynal MPC-6), and the unro- extraction with proteinase K, RNAse, and phenol-chloroform and
setted cells remaining in suspension were harvested by pipette. The precipitation in ethanol. The presence of Y chromosome-specific
beads were washed 3 times, and the supernatant pooled with the cell DNA sequences was assessed using a pY2-cDNA probe (donated
suspension. The unrosetted cells were further incubated with anti- by I. Lemischka, Princeton University, NJ).24 Five micrograms of
rat conjugated immunomagnetic beads at 47C for 20 minutes by each DNA sample was digested with the restriction enzyme Dra I,
adding a 4:1 bead:cell ratio, resulting in double the original cell and separated by gel electrophoresis in 0.8% agarose (GIBCO-BRL,
volume. Again immunomagnetic bead-rosetted cells were removed Bethesda, MD). DNA fragments were transferred onto Zetaprobe
using a magnetic particle concentrator, and the unrosetted cells re- nylon membranes (Biorad, Richmond, CA) according to established
maining in suspension were harvested by pipette. The beads were Southern blotting techniques. Sample loading variability was as-
washed 3 times, and the supernatant pooled with the cell suspension. sessed and adjusted for by reprobing membranes with a partial or
Rhodamine 123 (Rh)/Hoechst 33342 (Hoe) labeled cell separa- full-length cDNA for IL-3 (donated by J. Ihle and DNAX, Palo Alto,
tion. Immunomagnetically enriched cell suspensions were washed CA). Probes were labeled with 32P using a random primed labeling
and resuspended at 106 cells/mL in PBS 5% HI FCS and incubated kit (Boehringer Mannheim, Mannheim, Germany), and an autoradio-
in a final Rh concentration of 0.1 mg/mL for 20 minutes at 377C in graph made using Kodak XRP x-ray film (Eastman Kodak, Roches-
the dark. A final Hoe concentration of 10 mmol/L was then added, ter, NY). Blots were exposed to photostimulatable storage phosphor
and the cells incubated at 377C in the dark for a further hour. The imaging plates (Molecular Dynamics, Sunnyvale, CA), and the per-
cells were washed in ice-cold PBS 5% HI FCS and held on ice in centage of male and female DNA quantified after scanning the plates
preparation for sorting. with a 400A phosphorimager (Molecular Dynamics).
Labeled cells were analyzed on a FACStarplus cell sorter (Becton FISH. Cytospins were fixed in a 50% Carnoys (75% methanol/
Dickinson, Mountain View, CA) equipped with a 5-W argon ion 25% acetic acid) and 50% PBS solution for 10 minutes before being
laser (Coherent Innova 90, Palo Alto, CA) running at 200 mW of baked at 727C for an hour. The slides were then further fixed in 100%
power, and a 5-W argon ion laser (Coherent Innova 90) running at Carnoys for 5 minutes before permeabilization using proteinase K
50 mW of power. Light-scatter signals were collected through a (0.2 mg/mL) (Sigma Diagnostics, St Louis, MO) enzymatic digestion
488-nm band pass filter and a 1-decade logarithmic neutral density in 20 mmol Tris buffer at 377C for 1.5 minutes. The cytospins
filter in the forward light scatter path. Hoe fluorescence was collected were dehydrated through graded ethanol, then denatured in 70%
through a 424/44-nm band pass filter, and Rh fluorescence was formamide (GIBCO-BRL) in 2 1 SSC (0.3 mol/L NaCl and 0.03
collected through a 530/30-nm band pass filter. Cells with the prede- mol/L sodium citrate, pH 6.4) at 707C for 3 minutes. The slides
termined light-scatter properties of hematopoietic progenitors, were dehydrated once more, and hybridized with a digoxigenin-
termed ‘‘blast cells’’ and comprising approximately 10% of total labeled Y chromosome probe25 at 457C overnight. Unbound probe
BM cells,14 were analyzed and sorted at 47C on the basis of their was removed by stringent washings in 3 changes of 50% formamide
Hoe and Rh fluorescence. in 2 1 SSC and 2 changes of 2 1 SSC at 457C. Following a wash
The stem cell subset has been characterized as having both low in 4 1 SSC (0.6 mol/L NaCl and 0.06 mol/L sodium citrate, pH
6.4) at room temperature, the slides were blocked using a blockingHoe15-17 and Rh14,18,19 retention. Transplantable stem cells with long-
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Table 1. Engraftment of Rh/Hoedull Marrow Analysis of Spatial Distribution
Cells in Nonablated Recipients In situ detection of individual transplanted BM cells using FISH
% Male Cells on sections of paraffin-embedded whole murine femurs was done
% Male in Whole in Whole as previously described.26 Briefly, mice were perfused with 4% para-
Cloning Marrow Using Marrow formaldehyde into the descending aorta. Femurs were removed, de-Efficiency No. of Southern Blot Determined
calcified in EDTA, dehydrated in graded ethanol, and cleared inNo. Donor Cells %* Recipients Analysis† Using FISH‡
mineral spirits (Aldrich Chemical Co, Milwaukee, WI) before infil-
Rh/Hoedull
tration and embedding in Paraplast x-tra (Oxford Labware, St Louis,
2,600§ 82.3 12 1.4 { 0.2 1.7 { 0.2 MO).
3,000\ 88.7 9 0.9 { 0.07 1.1 { 0.2 Five micrometer femoral sections were mounted on 0.01% poly-
5,500§ 49.8 3 1.2 { 0.4 1.0 { 0.3 L-lysine (Mr 150,000-300,000; Sigma) subbed slides, deparaffinized
10,000§ 86.7 3 0.7 { 0.4 ND in xylene, and rehydrated in graded ethanol. The formaldehyde from
10,000§ 81.3 5 2.2 { 0.4 3.4 { 0.4
the original fixation was inactivated in 0.1 mol/L glycine, before
Whole marrow permeabilization using proteinase K (5 mg/mL) enzymatic digestion.
100 1 106§ ND 23 24.9 { 1.9 ND The sections were further fixed in fresh paraformaldehyde, prehy-
bridized, and following denaturation, hybridized with the digoxi-Abbreviation: ND, not done.
* The cloning efficiency represents the proportion of 7 factor (IL-1, genin-labeled Y chromosome probe. Unbound probe was removed
IL-3, CSF-1, GM-CSF, G-CSF, SCF, and FGF), responsive HPP-CFC after by stringent washings.
14 days in a double-layer agar culture. Nonspecific binding of the detection fluorochrome was blocked
† Values are the means { SEM. Southern blots were probed with using a skim milk blocking buffer. Detection of digoxigenin was
pY2 and the percentage male was determined using phosphorimage done using anti-digoxigenin-rhodamine Fab fragments. To preserve
analysis, taking the male to be 100% and the female as 0%. Loading fluorescent labeling, sections were mounted in Vectashield.
variability was corrected using an IL-3 probe.
RESULTS‡ Values are the means { SEM representing analysis of at least 300
cells from at least 4 different fields of focus. FISH analysis was done To accurately assess the extent of donor chimerism of
using a Y chromosome-specific painting probe. Male slides were hematopoietic cells and the histological location of these
100%, and female slides 0% following this analysis.
engrafted cells, we used several techniques that rely on the§ Analyzed 6 weeks posttransplant.
detection of Y chromosome-specific (donor) DNA se-\ Analyzed 6 months posttransplant.
quences. These included Southern analysis and in situ hy-
bridization analysis of both single cell suspensions and paraf-
fin embedded femoral sections.
buffer consisting of 5% FCS, 5% nonfat milk (Shaw’s, Bridgewater, Stem cell engraftment. Six weeks to 6-months posttrans-
MA), and 0.05% Triton X-100 (Sigma) in 4 1 SSC for 15 minutes. plant, 2,600 to 10,000 male donor stem cells (Rh/HoedullDetection of digoxigenin was done using antidigoxigenin-rhoda-
cells) successfully engrafted into the marrow of nonablatedmine, Fab fragments (Boehringer Mannheim), at a concentration of
female hosts. Southern blot analysis of whole marrow to6.5 mg/mL in PBS containing 2% bovine serum albumin fraction V
detect Y chromosome-specific DNA sequences in female(Sigma) for 30 minutes in the dark. Nonbound antibody was removed
hosts clearly showed the presence of donor cells in multiplethrough 3 extensive, light protected, washings; first in 4 1 SSC for
10 minutes, then in 4 1 SSC containing 0.05% Triton X-100 for 10 experiments (Table 1, Fig 1). This low level engraftment
minutes, and finally in 4 1 SSC for 10 minutes. Cytospins were was confirmed by FISH on BM cell suspensions (Table 1).
counterstained in 0.4 mmol DAPI (4,6-diamidino-2-phenylindole)
(Sigma) and mounted in the antifade media Vectashield (Vector,
Burlingame, CA). Specific positive label was confirmed under the
microscope by a visual check at excitation and emission wavelengths
other than that of rhodamine. Samples were analyzed by multiple
readers for verification of results.
Analysis of multilineage potential. Peripheral blood was col-
lected from mice injected with 4,500 Rh/Hoedull cells 6 weeks post-
transplant. Red cells were lysed using 0.83% ammonium chloride
at 377C for 5 minutes. Residual cells were washed twice, first in
PBS and then in PBS 5% HI FCS. Individual cell aliquots were
labeled with the lineage specific primary antibodies MAC-1, GR-1,
B220, or CD4/CD8 as described above. After a 15-minute incubation
on ice, the labeled cells were washed in PBS 5% HI FCS and
resuspended in the same initial volume. The cells were incubated
with mouse serum-absorbed fluorescein isothiocyanate (FITC)-con-
jugated goat anti-rat IgG (Southern Biotechnology Associates, Bir-
mingham, AL) at 47C for 20 minutes in the dark. The cells were
washed in PBS 5% HI FCS and held on ice until sorted. Each
Fig 1. Percentage of male DNA in BM of individual recipient female
subpopulation was analyzed and sorted by the same FACStarplus mice. Female mice received 2,600 Rh/Hoedull marrow cells and were
cell sorter described above. Background fluorescence (cell surface sampled 6 weeks posttransplant. Southern blots were labeled using
binding of FITC-conjugated goat anti-rat second antibody) was less a Y chromosome-specific probe and the percentage donor calculated
than 5%. Positive cells were collected into individual tubes, and by phosphorimage analysis, taking the male as 100% and the female
as 0%. Loading variability was corrected using a probe for IL-3.analyzed for donor cells using the FISH method described above.
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Table 2. Analysis of Multilineage Potential ablated recipients. These cells were shown to proliferate and
differentiate with multilineage potential, representing an% Subpopulation in % Male in Each
Peripheral WBC* Subpopulation† equivalent proportion of the host primitive Rh/Hoedull com-
partment to that observed in host unseparated BM. However,MAC-1 13.8 { 2.7 0.4 { 0.2
the level of engraftment observed was significantly lowerGR-1 7.5 { 0.6 1.0 { 0.6
B220 16.1 { 3.1 2.2 { 0.6 than that expected following a transplant of equivalent whole
CD4/CD8 24.3 { 2.0 0.3 { 0.3 marrow.
Murine hematopoietic stem cells have traditionally beenMice were injected with 5,500 Rh/Hoedull cells and harvested 6 weeks
defined by their ability to repopulate the marrow of a lethallyposttransplant. The percentage donor cells in the BM as determined
by FISH was 1.0 { 0.3%. Peripheral blood was collected, and the red irradiated recipient. The stem cell compartment has been
blood cells lysed using ammonium chloride. characterized as having both low Hoe15-17 as well as low
* White cells were labeled for macrophages (MAC-1), granulocytes Rh14,18,19 retention. Transplantable stem cells with long-term
(GR-1), B cells (B220), and T cells (CD4/CD8). reconstituting ability were shown to be within the 1st through
† Each peripheral white blood cell (WBC) subpopulation was ana- 3rd Hoe fluorescence percentiles and 1st through 15th Rh
lyzed for donor cells by FISH using a Y chromosome-specific painting fluorescence percentiles (Rh/Hoedull).20 Repopulation of irra-
probe. Values are the means { SEM. diated hosts has been achieved from as few as one or two
stem cells with the help of mature support cells enabling theSix weeks posttransplant, the multilineage potential of
mouse to survive while the stem cells amplify and feed out.
transplanted cells was accessed by analysis of peripheral As such, the irradiated host represents an amplification unit,
white blood cells from mice transplanted with 4,500 Rh/ providing a high yield from a small number of donor cells.Hoedull cells. White blood cells were sorted into lineage sub- As a consequence, this model was easily applied to the clinic,populations, and each subpopulation analyzed for donor cells
where irradiation removed diseased cells, and reconstitutionby FISH, using a Y chromosome-specific painting probe
only required relatively small numbers of donor cells. How-(Table 2). Rh/Hoedull cells were shown to home, proliferate,
ever, cytoablative preparative treatment severely damages
and differentiate, forming a detectable proportion of the mac- the hematopoietic microenvironment. In addition, cytoabla-
rophage (MAC-1), granulocyte (GR-1), B-cell (B220), and tive treatment is not desirable or feasible for many diseasesT-cell (CD4/CD8) subpopulations. In the lineages analyzed,
as it has multiple associated risks to the patient. As a conse-donor cells comprised 2.9%, 13.3%, 13.7%, and 1.2%, re- quence, there are many clinical advantages of a nonablated
spectively, of each lineage subpopulation. transplant model.Pooled marrow from mice transplanted with either 2,600 or In our experience, the proportion of primitive cells (Rh/10,000 Rh/Hoedull cells was resorted for cells with the same Hoedull cells) in the marrow is approximately 0.003%, orRh/Hoedull characteristics of the cells initially seeded. FISH 3,000 in 100 1 106 whole BM cells. Using Southern blot
analysis of the proportion of donor cells within this subpopula-
analysis of male into female transplant recipients we have
tion (2.2% and 4.7%, respectively) (Fig 2) was equivalent to
shown approximately 25% donor cells in the marrow 6
that found in the whole marrow. This highlights the mainte-
weeks after a transplant of 100 1 106 whole BM cells into
nance of a significant population of donor cells with a primitive
nonablated hosts (Table 1). Assuming that this long-termRh/Hoedull phenotype. In addition, the data show for the first
engraftment comes from the primitive Rh/Hoedull cell popula-
time that the analysis of whole marrow in nonablated hosts is tion, we would expect the proportion of Rh/Hoedull cells
a true reflection of the proportion of donor cells within the
engrafted into the marrow to reflect that seen following trans-primitive Rh/Hoedull stem cell compartment. plants with equivalent numbers of whole marrow. However,Spatial distribution of engrafted cells. The application
our data showed only between 0.8% and 6.4% of these ex-
of our new FISH technique on sections of paraffin embedded pected values (Table 4).
whole femurs allowed the identification of individual en- It is unlikely that this significantly reduced percentage ofgrafted cells ex vivo. Animals receiving Rh/Hoedull cells were donor cells is the consequence of an immune mediated rejec-
analyzed 6 weeks posttransplant. In all animals analyzed,
tion against the H-Y (Y chromosome-associated histocom-
engrafted cells had a strong spatial association for the endos- patibility) antigen. BALB/c H-2D mice were specificallyteal surface (Table 3, Fig 3C), and in none of the samples
chosen for this series of experiments because of their very
were any donor cells found in the central marrow region. low degree of immunoreactivity to the H-Y antigen.28 TheseAll of the donor cells detected were within 6 cells of the
mice have previously been shown not to reject skin grafts
endosteal surface, except for one donor cell which was
from the opposite sex.29 In addition, previous transplant ex-
within 12 cells of the endosteal surface. After a transplant
periments reported from this laboratory show expected levelsof Rh/Hoedull cells, donor cells almost always occurred as
of engraftment following the transplant of male whole BMsingle entities. This distribution was unlike that seen follow-
into nonablated female recipients,30 and this remains throughing a transplant of 100 1 106 whole marrow cells, where
25 months, the normal life span of a mouse.7 Together withengrafted cells were seen distributed throughout the marrow
the results of the whole BMT reported in the present study,as both large clusters as well as single cells (Fig 3E).
which resulted in the expected levels of donor cell en-
DISCUSSION graftment 6 weeks posttransplant, these data give no indica-
tion of any immune mediated rejection in this transplantWe have shown that transplanted purified hematopoietic
stem cells (Rh/Hoedull cells) engraft into the marrow of non- model.
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Fig 2. A cytospin of pooled marrow from mice transplanted with
10,000 Rh/Hoedull cells and resorted for cells with the same Rh/Hoedull
characteristics of the cells initially seeded. (A) Cells are stained using
in situ hybridization for a digoxigenin-conjugated Y chromosome-
specific ‘‘painting’’ probe and visualized with rhodamine using a 590-
nm longpass filter. Positive cell (d) is of donor origin, while unlabeled
cells (h) are of host origin. (B) Same as (A) except counterstained
with DAPI, excited with UV, and visualized using a 450-nm longpass
filter. Original magnification (OM) Ì 313.
r
It is also unlikely that the lower than expected percentage
of donor cells 6 weeks after transplant is due to a lag phase
of these cells, as very similar results were obtained after 6
months (Table 1). In addition, because of the very low num-
ber of cells transplanted, detection of donor cells relies on
the proliferation of those initially injected. Not only were
cells detected, but they comprised an equivalent proportion
of mature circulating peripheral blood cells, whole BM cells,
as well as Rh/Hoedull marrow cells. These findings show that
the transplanted cells are proliferating as well as differentiat-
ing.
The data suggest that an accessory, or facilitator cell inter-
action may be important for optimal stem cell engraftment
Fig 3. Femoral BM sections from BALB/c mice:
(A) male, (B) female, (C) female 6 weeks posttrans-
plant with 2,500 Rh/Hoedull marrow cells, and (E) fe-
male 6 weeks posttransplant with 100 Ì 106 whole
marrow cells. Sections are stained using in situ hy-
bridization for a digoxigenin-conjugated Y chromo-
some-specific ‘‘painting’’ probe and rhodamine anti-
digoxigenin (arrows) and visualized using a 590-nm
longpass filter. (D) and (F) same as (C) and (E), re-
spectively, except counterstained with DAPI, excited
with UV, and visualized using a 450-nm longpass
filter. Arrows point to corresponding Y chromosome-
positive cells. (es) Endosteal surface; the actual bone
is removed during the denaturing step of the in situ
hybridization. Sections are mounted in Vectashield
antifade. OM Ì 746 (A through D); OM Ì 500 (E and
F).
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Table 3. Analysis of the Spatial Distribution of Rh/Hoedull Cells and concentration in regions close to the inside of the femoral
Their Progeny 6 Weeks Posttransplant bone, in an association with a decrease in committed precur-
sor cells of the granulocytic lineage. Although these progeni-Section No. Central Marrow
Analyzed* Region Endosteal Region tors are now known to be more mature than a stem cell, the
data in combination with the observation that CFC, an even1 0 /
2 0 0 more mature subset of hematopoietic progenitor cells, in-
3 0 0 crease toward the central marrow region34 suggest more
4 0 / primitive cells lie closest to the endosteal surface. Gong35
5 0 0 also showed that cells isolated from the endosteal bone sur-
6 0 / face were enriched for colony-forming units. These findings
7 0 /
were independently confirmed using mainly histological pro-
8 0 /
cedures36,37 and reconfirmed more recently using a technique9 0 /
capable of fractionating the diaphyseal marrow cavity into10 0 0
distinct zones consisting of cells lying close to bone and11 0 /
those lying more centrally.3412 0 /
13 0 / Lord38 also noted a high spatial association of primitive
14 0 0 hematopoietic progenitor cells (CFU-s) and endosteal sur-
faces, suggesting that hematopoietic stem cell differentiationP  .004 using a two-side paired-sample sign test, based on the
occurs in direct proximity to endosteal osteoblasts within theassumption that donor cells have an equal probability of being in the
central marrow region as at the endosteal surface (defined as 12 cells marrow cavity. These observations have since been ex-
from the femoral marrow interface).27 panded in vitro using a long-term culture initiating primitive
Abbreviations: 0 Represents no donor cells detected; / cells of progenitor cell population (LTC-IC).39 This study suggests
donor origin detected. that not only do osteoblasts support primitive hematopoietic
* Sections were analyzed from at least 4 different mice from 3 differ- LTC-IC, but that the presence of these cells at the endosteal
ent experiments.
surface may also be due to a requirement for osteoblast-
derived factors. Compared to the CFU-s, these cells are much
more equivalent to the stem cell in their level of the hemato-in a nonablated syngeneic transplant. Previous studies have
poietic hierarchy.40also indicated a requirement for a facilitator cell interaction.
Because of the technical impossibility of obtaining enoughKaufman et al31 identified a potential marrow accessory cell
donor ‘‘stem cells’’ to be able to detect these cells in thepopulation, separate from hematopoietic stem cells, that fa-
marrow in situ at very short time intervals posttransplant,cilitates engraftment of purified allogeneic marrow stem cells
we had to rely on the engrafted cells proliferating to analyzein a major histocompatibility complex-specific fashion, in
their spatial distribution. As a consequence, analysis wasthe absence of graft-versus-host disease. The same group
done at 6 weeks posttransplant. At this time, donor cells,more recently showed the same phenomena of these marrow
which consisted of progenitor cells, mature cells, and cells‘‘facilitator cells’’ with the engraftment of fetal liver stem
with the very primitive Rh/Hoedull stem cell characteristics,cells in allogeneic transplants.32 Following lethal irradiation,
had a very high spatial association with the endosteal surface.it was suggested that such ‘‘facilitator cells’’ were not re-
However, it remains possible that these cells initially homedquired for syngeneic transplants. Our data further support
to another marrow region and migrated to this area postpro-the existence of a ‘‘non-stem cell facilitator population,’’
liferation. A definitive answer will require further technicalbut suggest that these cells are also required in a nonablated
syngeneic transplant setting.
Our data also suggest a spatial localization of stem cell
‘‘niches’’ to the endosteal surface, with all donor cells hav- Table 4. Evidence for An Accessory Cell Interaction
ing a very high spatial affinity to this area. Even though
Actual % Male inthe location of stem cell niches still remains a matter for
No. Whole Marrow
speculation, mounting evidence does suggest that they may Donor % Male Expected From Rh/Hoedull
Rh/ No. of Starting From Equivalent Cells Using % ofbe in intimate association with bone. Histological examina-
Hoedull Whole Marrow Whole Marrow Southern Blot Expectedtion of bones during recovery from hematopoietic depletion Cells Cells (1106) Cells* Analysis Value
as a result of sublethal doses of irradiation shows that repop-
2,600 87 22 1.4 6.4
ulation, as evidenced by the appearance of hematopoietic
3,000 100 25 0.9 3.6precursors, is first seen along the endosteal surface.4 Follow- 5,500 183 46 1.2 3.3
ing the use of x-rays, this region has received the highest 10,000 333 83 0.7 0.8
dose of irradiation, enhancing the significance that regenera- 10,000 333 83 2.2 2.6
tion begins from an area with the least cell survival.
* The expected values for 100 1 106 whole marrow cells was deter-Previous studies have also indicated that BM cell popula- mined from Southern blot analysis of at least 3 previous experiments
tions conform to a well-defined spatial organization, with a giving these equivalent numbers of whole marrow cells. The expected
relationship between location and the development of the values for the other whole marrow cell doses were theoretically calcu-
various hematopoietic cell lineages. Lord et al33 showed an lated based on a linear relationship between the number of cells given
and the % donor cells detected at 6 weeks to 6 months.increase in progenitor spleen colony-forming cell (CFU-s)
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